Daily Stock List
New Energy Technologies, Inc. (NENE)
Energy and Capital, StockEgg, PennyStockVille, HotOTC, MadPennyStocks, StockRich, BullRally, and CoolPennyStocks reported previously on New Energy Technologies, Inc. (NENE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
New Energy Technologies, Inc., together with their wholly owned subsidiaries, is a developer of next generation alternative and renewable energy technologies. The Company is a development stage enterprise developing two sustainable electricity-generating systems. The novel technologies have branding as SolarWindow™ and MotionPower™. New Energy Technologies has their corporate headquarters in Columbia, Maryland.
SolarWindow™ technologies enable see-through windows to generate electricity by 'spraying' their glass surfaces with the Company's electricity-generating coatings. These solar coatings are less than 1/10th the thickness of 'thin' films. They make use of the world’s smallest functional solar cells. The Company's SolarWindow™ Technology provides the ability to harvest light energy from the sun and artificial sources and generate electricity from a see-through, semi-transparent, coating of OPV solar cells. This SolarWindow™ Technology is the subject of 14 patent filings.
New Energy Technologies' MotionPower™ Technology harvests "kinetic" or "motion" energy from vehicles when they slow down before coming to a stop. It converts this captured energy into electricity. This MotionPower™ Technology is the subject of 45 patent filings.
Last month, New Energy Technologies announced that they entered into Phase 2 of their Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Energy's National Renewable Energy Laboratory (NREL) to advance the development of their SolarWindow™ technology. Together, they and NREL plan to advance New Energy's electricity-generating device by enhancing performance, processing, and lifetime. Under the terms of the agreement, researchers will additionally work towards optimizing the deposition of different coatings on flexible surfaces.
Future development plans include efforts to improve SolarWindow™ efficiency and transparency further; optimize electrical power (current and voltage) output; optimize the application of the active layer coatings that make it possible for SolarWindow™ to generate electricity on glass surfaces; and develop improved electricity-generating coatings by enhancing performance, processing, reliability, as well as durability.
Future development plans additionally include optimizing SolarWindow™ performance on flexible substrates, and developing high speed and large area roll-to-roll (R2R) and sheet-to-sheet (S2S) coating methods needed for commercial-scale BIPV and windows.
New Energy Technologies, Inc. (NENE), closed Monday's trading session at $1.60, up 6.67%, on 193,387 volume with 188 trades. The average volume for the last 60 days is 30,779 and the stock's 52-week low/high is $0.75/$2.70.
Red Giant Entertainment, Inc. (REDG)
PennyStockLocks.com reported last week on Red Giant Entertainment, Inc. (REDG). PennyStocks24, Penny Stock Newsletter, PREPUMP STOCKS, Damn Good Penny Picks, Stock Roach, StockHideout, StockMister, Stock Exploder, MyBestStockAlerts, Penny Stock Pulse, StockBomb.com, StockLockandLoad, StockRockandRoll, PremiereStockAlerts, Otcstockexchange, and Whisper from Wall Street did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.
Red Giant Entertainment, Inc. is an intellectual property (IP) development company. The intention of their properties (comic book style) is to undergo development for the comic book market and for use in other media (movies, video games, and television, novels, toys, apparel and telephone wireless applications). The Company's business plan is to either engage in the direct production of their properties or enter into licensing agreements with others. Red Giant has several movies in different stages of production, and more are currently undergoing development. Red Giant Entertainment is based in Clermont, Florida.
The Company's core business is dedicated to developing quality intellectual properties, while serving their advertisers. Red Giant is currently the largest publisher of exclusive comic book format material on the internet. Their print division is positioned to become the largest globally, with an annual circulation of over 52 million. Each week a new comic book targeting a different audience demographic will undergo distribution at one million copies across the network. Red Giant Entertainment has more than 36 titles in their library.
The intention of the products is for them to be available for others to purchase advertising on terms and conditions to be determined by the licensee of the product. Red Giant intends to retain a royalty for the product and for the included advertising content. Merchandise revenue related to the product will also be available to Red Giant on terms and conditions to be negotiated between the licensee and the Company or retained by the Company.
Last week, Red Giant Entertainment announced the filing of their audited results for the second quarter ending February 28, 2013. Gross Profit increased from $9,708 during the six months ended February 29, 2012 to $84,620 during the six months ended February 28, 2013. Net income for the six months ended February 28, 2013 was a net profit of $30,399, in comparison to a net profit of $4,364 during the six months ended February 29, 2012. This represents an increase of $26,035 or 597 percent.
During the three months, ended February 28, 2013, revenues were $59,591. This represents an increase of $51,437 or 631 percent from $8,154 for the three months ended February 29, 2012. Gross Profit increased from $3,669 during the three months ended February 29, 2012 to $26,157 during the three months February 28, 2013.
Today, Red Giant Entertainment announced that they would be participating in the San Diego Comic-Con again. The Company will be participating at a larger and more prominent booth in association with strategic partner Keenspot. San Diego Comic-Con has grown to more than 130,000 comic enthusiasts attending the show in 2012.
Red Giant Entertainment, Inc. (REDG), closed Monday's trading session at $0.0124, up 7.83%, on 4,459,543 volume with 119 trades. The average volume for the last 60 days is 7,153,624 and the stock's 52-week low/high is $0.0081/$0.26.
Blue River Resources Ltd. (BXR.V)
We are reporting on Blue River Resources Ltd. (BXR.V) today, here at the QualityStocks Daily Newsletter.
Based in Vancouver, British Columbia (B.C.), Blue River Resources Ltd. is a mineral exploration and development company. Their focus is on discovering and developing copper deposits in the Quesnel Trough Copper Belt of B.C. and Washington. Their projects include the Highland North Project and the Castle Copper Project. Blue River Resources lists on the TSX Venture Exchange.
Blue River Resources' Phase I diamond drill program on the Highland North Project, conducted in September 2012 , totaled 1,182,56 meters of NQ drillcore over 5 holes from 5 drill sites. The program resulted in 479 samples collected and submitted for assays. Diamond drill hole BXR-12-2 intersected 39.65 meters (130 feet) grading 0.1 percent copper, from 30.85 meters (101.2 feet) to 70.05 meters (229.8 feet). Drill hole BXR-12-2 was the only hole to have reportable mineralization. The Company has no further exploration planned for the Highland North Project.
The Company holds a 100 percent interest in the 18,000-acre Castle Copper Project. This Project is 25 kilometers north of Copper Mountain Mining. The Castle project is directly north of Sego Resources' Miner Mountain property and directly south of Westar's Axe Copper Project, currently under joint venture with Xstrata Copper. Blue River drilled 3 short reconnaissance diamond drill holes in September of 2012 totaling 123 meters (407 feet); they encountered no significant mineralization. Their current exploration plans for the Castle Copper project include an extensive ground IP and mag survey over the 7 kilometers of the Nicola fault that trends through the Castle property.
At the end of February, the Company announced that they acquired an option to earn a 100 percent interest in the Mazama Copper deposit in Okanogan County, Washington. The Company has agreed to grant the vendor a 3 percent Net Smelter Royalty (NSR), of which 2 percent can be purchased by Blue River for $3.0 million.
Last month, Blue River Resources announced exploration plans for 2013 for the Mazama Copper deposit, located in Okanogan County, Washington. The Company's exploration plans for this year include confirmation and expansion of the historic Non 43-101 compliant resource developed by Quintana Minerals Corp. Blue River's 2013 exploration programs will consist initially of a property wide geophysical (magnetics) survey. This will be followed by a detailed surface mapping and sampling program. The Company's intention is to permit a diamond drilling program this year, which will allow a confirmation of the historically reported copper mineralization.
Blue River Resources Ltd. (BXR.V), closed Monday's trading session at $0.10, even for the day, on 232,000 volume. The stock's 52-week low/high is $0.06/$0.17.
Great Basin Gold Ltd. (GBGLF)
We are highlighting Great Basin Gold Ltd. (GBGLF), here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Great Basin Gold Ltd. is an international gold mining company that has two emerging mines in the world's richest gold regions. One is the Hollister Mine on the Carlin Trend in Nevada, U.S.A. The other is the Burnstone Mine in the Witwatersrand Basin, South Africa. Moreover, Great Basin Gold has prospective exploration projects in Mozambique and Tanzania. Their strategy includes developing gold projects and assets into high margin mining units; continuing to increase their reserve and resource base by way of exploration; and acquiring companies and assets suited to expanding their business. Great Basin Gold has offices in Vancouver, British Columbia, and Sandton, South Africa.
The Company's Nevada Operations (Gold & Silver) consist of the Hollister Property in the northeastern part of the Carlin Trend, approximately 80 kilometers from Elko, Nevada, and the Esmeralda Property in the southwest, close to the border between Nevada and California and approximately 467 kilometers from Hollister. The Company has 100 percent ownership. The property area is 27 sq miles/69 sq km/ 6,900 ha/17,050 acres.
Their Burnstone Property (Gold) is in the South Rand area of the Witwatersrand Goldfields in Mpumalanga Province, approximately 80 kilometers southeast of Johannesburg, South Africa. It is a 100 percent owned and operated property of Great Basin Gold. The Company began commercial production in February 2011. The Burnstone Property infrastructure includes the Property being close to a major paved highway; power from the national grid (Eskom), and two rail lines and a water pipeline. The property area is 134 sq miles/347 sq km/34,654 ha/85,633 acres.
In Tanzania, exploration programs are taking place in two separate geological terrains: the Archean, greenstone-hosted, Lake Victoria Goldfields (north-west) and the Proterozoic Lupa Goldfields (south-west). Great Basin Gold also manages a joint venture with African Barrick Gold Plc in the Geita Belt of the Lake Victoria Goldfields.
In addition, the Company holds an 80 percent interest in an unincorporated joint venture with G S Minase Refnaria Limitade (GSR) in Mozambique. The purpose of the joint venture is to establish a gold exploration and mining business in Mozambique, where Great Basin Gold will have the exclusive right to explore all of GSR's properties.
Great Basin Gold Ltd. (GBGLF), closed Monday's trading session at $0.009, up 9.76%, on 1,185,719 volume with 30 trades. The average volume for the last 60 days is 3,742,854 and the stock's 52-week low/high is $0.007/$0.08.
Norstra Energy, Inc. (NORX)
PennyStocks24, InvestorPlace, YOLOTraderAlerts, The Trading Report, The Stock Enthusiast, Todd Horwitz, Oakshire News Bulletin, Penny Stock Professor, SUPERSTOCKPLAYS, Oakshire Financial, and Investors Alley reported recently on Norstra Energy, Inc. (NORX), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Founded in 2010, Norstra Energy, Inc. is an oil and natural gas exploration company whose shares trade on the OTC Markets' OTCQB. The Company is focusing their exploration efforts in the under-exploited southern portion of the Bakken-Alberta Fairway in the central portion of western Montana. Norstra's business plan will consist of drilling high probability wells within this flourishing area. Norstra Energy has their headquarters in Southlake, Texas. The Company previously went by the name Norstra, Inc. They changed their name to Norstra Energy, Inc. in November of 2011.
The South Sun River Bakken Prospect is an over-pressured Bakken shale resource play in Lewis & Clark County, Montana. It is in the developed Bakken Fairway, which extends southwards from Alberta, into northwest Montana. Norstra Energy has interests in more than 10,000 acres of prime Bakken formation land in Montana. The Company is targeting this South Sun River Prospect for a horizontal Bakken well proving the prospect from exploration to production.
Today, Norstra Energy announced that their management and technical team met with the Company's operator to review current operations and establish detailed guidelines for the planned drilling program on the South Sun River Project. At present, Norstra has more than 14 miles of seismic lines ordered from QEP Resources (QEP) and PacSeis. The expectation is that the reprocessed seismic data will be in place within a couple of weeks.
Preliminary review of the seismic suggests a significant amount of thrust sheets in the area. Norstra Energy has requested additional acreage from Summit West Oil where the blocks have been noted from the preliminary review. Summit West agreed to add two full sections (1,280 acres) to the project based on the same terms as the original Farmout Agreement. This brings the total prospect size to more than 11,300 acres.
Mr. Glen Landry, the Chief Executive Officer of Norstra Energy, stated, "Adding the additional acreage at this point is a very important step for Norstra to ensure that we give the company and our investors the best possible opportunity to drill the first wells on our lands. We were always planning to increase our land position over time, and after reviewing the first technical data during the operational meetings, we decided to accelerate that process. Everybody is looking forward to getting the surface casing set for the first test."
Norstra Energy, Inc. (NORX), closed Monday's trading session at $0.58, up 2.65%, on 1,039,173 volume with 356 trades. The average volume for the last 60 days is 185,338 and the stock's 52-week low/high is $0.35/$0.62.
Sunvalley Solar, Inc. (SSOL)
FeedBlitz, PennyTrader Publisher, WiseAlerts, and Stockpalooza reported earlier on Sunvalley Solar, Inc. (SSOL), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.
Headquartered in Los Angeles, California, Sunvalley Solar, Inc. is a solar power technology and system integration enterprise. The Company offers complete solar energy technology, system design, installation, equipments, and technical support. They offer these for electrical contractors, builders, homeowners, businesses/commercial buildings, and government entities. The Company provides an all-in-one service for customers' solar system needs - from system design and permitting, to installation and final inspection. Sunvalley Solar lists on the OTC Markets' OTCQB.
The Company is a leading solar electric equipment wholesale distributor for solar photovoltaic equipment of manufacturers including CEEG-SST and Canadian Solar, Inc., in addition to PV Powered and SMA Sunny Boy Inverters, and ProSolar for racking system products.
Sunvalley Solar specializes in packaged solar system solutions. At present, they distribute to over 600 clients in more than 21 states. They provide solar equipment as well as technical support.
Sunvalley Solar has designed and installed more than two million watts of solar power systems. Their experience includes residential, small commercial, and complex large commercial solar system integration projects. The projects include 975kW commercial solar power systems for distribution warehouses and manufacturing companies, as well as 1MW commercial solar power systems for agriculture farms and cold storage facilities.
Last week, Sunvalley Solar announced that they were awarded a new 129.5 KW solar system installation contract from Amerifreight, Inc in City of Industry, California. The contract is for a system that can generate 190,688 kWh of electrical power each year. The system uses 518 pieces of high efficiency 250-watt Polycrystalline solar panels. The project installation will start by the middle of this year.
Mr. James Zhang, Chief Executive Officer of Sunvalley Solar, said last week, "This is our second solar energy system installation contract for Amerifreight in 2013 at their facility in City of Industry. Our commitment to quality and total customer satisfaction is evident in the award of this second installation contract. Our work speaks for itself and we look forward to helping more commercial owners achieve the best energy solutions while making a positive environmental impact."
Sunvalley Solar, Inc. (SSOL), closed Monday's trading session at $0.013, up 88.41%, on 28,151,295 volume with 853 trades. The average volume for the last 60 days is 1,314,516 and the stock's 52-week low/high is $0.0029/$1.00.
Liquidmetal Technologies, Inc. (LQMT)
FeedBlitz, Stock Analyzer, StreetInsider, and Greenbackers reported earlier on Liquidmetal Technologies, Inc. (LQMT), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Based in Rancho Santa Margarita, California, Liquidmetal Technologies, Inc. is the leading developer of bulk alloys and composites that use the performance advantages that amorphous alloy technology offers. Amorphous alloys are unique materials distinguished by their ability to retain a random structure when they solidify. This is in contrast to the crystalline atomic structure that forms in ordinary metals and alloys. The Company is the first enterprise to produce amorphous alloys in commercially viable bulk form. This is enabling significant improvements in products across a wide spectrum of industries.
Liquidmetal Technologies' unique class of patented alloys and processes form the basis of high performance materials used in an extensive array of medical, military, consumer, and industrial and sporting goods products. The Company controls the intellectual property (IP) rights with over 50 U.S. patents. Their alloys are, in many cases, stronger, harder, more elastic, and more wear and corrosion resistant than commonly used high-performance alloys. Liquidmetal has two to three times the strength of titanium and stainless steel.
They are processed similar to plastics on the Company's proprietary Liquidmetal molding machines. Liquidmetal is processed and solidified in a vitreous or amorphous state (frozen liquid). Their "bulk" amorphous alloys possess advantages usually associated with plastics. This includes the ability to undergo molding into precision, complex, and highly finished products.
Earlier this month, the Company reported an increased level of Liquidmetal prototypes parts shipped to major players in their targeted industries during the first quarter of 2013. During the first quarter, Liquidmetal Technologies delivered five new prototype shipments to five different customers. This represents an increase of 67 percent from the prior quarter and compares to none in the same year-ago period. Each shipment contained multiple prototype parts.
Today, Liquidmetal Technologies announced that they would hold a conference call on Monday, May 13, 2013 at 4:30 p.m. Eastern Time to discuss results for the first quarter ended March 31, 2013. Financial results will be issued in a press release after the close of market on this day. Company President and Chief Executive Officer, Mr. Tom Steipp and Chief Financial Officer, Mr. Tony Chung, will host the presentation, followed by a question and answer period.
Liquidmetal Technologies, Inc. (LQMT), closed Monday's trading session at $0.085, up 4.81%, on 1,105,162 volume with 105 trades. The average volume for the last 60 days is 1,747,301 and the stock's 52-week low/high is $0.076/$0.6349.
Aurcana Corp. (AUNFF)
Monster Stocks Picks and Stock Stars reported this month on Aurcana Corp. (AUNFF), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
Aurcana Corp. is a Canadian junior mining company with corporate headquarters in Vancouver, British Columbia. They own 100 percent of the Shafter silver mine (Presidio County, S.W. Texas) and 99.9 percent of the La Negra (Queretaro State, Mexico) silver-copper-lead-zinc mine. Aurcana engages in the production and sale of copper, silver, lead, and zinc concentrates. The Company also engages in the exploration, development, and operation of natural resource properties. Aurcana lists on the OTCQX International.
Exploration is continuing at Shafter and La Negra. The Shafter silver mine has an NI 43-101 silver resource of 24.6 million ounces Measured and Indicated (2,900,000 tons @ 8.48 opt), 22.8 million ounces Inferred (2,167,000 @ 10.52 opt). It has a pre-feasibility completed. Production is forecast at 3.8 million ounces silver recovered once the mine and mill is operating at capacity.
In 2009, La Negra was milling 1,000 tonnes per day; by 2012, the capacity was expanded to 2,500 tonnes per day. In 2013, the expectation is that capacity will be expanded to 3,000 tonnes per day. A new NI 43-101 report was released for La Negra in August of 2012. It identified 115 million ounces of measured and indicated silver underground, changing the mine life to a minimum of 30 years.
Recently, Aurcana report their audited financial results for the fourth quarter and year-end as of December 31, 2012. Selected highlights include total revenues for 2012 of $56.9 million, up 20 percent from $47.5 million in 2011. Revenues in Q4 2012 were $16.3 million; this represents a 48 percent increase from $11 million in Q4 2011.
Total silver ounces equivalent production for 2012 was 2,523,441. This is up 45 percent from 1,741,705 ounces produced the year prior. Silver ounces equivalent production for Q4 2012 was 624,159, up 33 percent from 468,343 in Q4 of 2011.
Earnings from mining operations in 2012 were $25 million. This represents an increase of 8 percent from $23.2 million in the prior year. Earnings from mining operations in Q4 2012 were $7.6 million. This is up 33 percent from $5.7 million in Q4 2011. Net income in 2012 was $10 million; this represents an increase of 30 percent from $7.7 million in 2011.
Aurcana Corp. (AUNFF), closed Monday's trading session at $0.4699, up 7.04%, on 1,075,251 volume with 181 trades. The average volume for the last 60 days is 1,728 and the stock's 52-week low/high is $0.51/$0.10.
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.07, up 7.69%, on 2,393,998 volume with 113 trades. The stock’s average daily volume over the past 60 days is 3,440,543, and its 52-week low/high is $0.0275/$0.155.
Advaxis, Inc. announced signage of an MoU with Taiwain-based biopharma developer FusionVax today that will see the company's lead clinical stage product candidate, ADXS-HPV, exclusively licensed for Asia after the eventual definitive agreement is drawn up. Also announced today was dosing of the very first patient enrolled in the company's Phase 1/2 study of ADXS-HPV in 25 patients with HPV-associated anal cancer, currently being coordinated by the Brown University Oncology Research Group, successfully mapping a third tumor type under clinical investigation by ADXS-HPV.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis and FusionVax Sign a Memorandum of Understanding for the License of Advaxis’ ADXS-HPV in Asia
Advaxis Announces First Patient Dosed in Brown University Sponsored Anal Cancer Study
Advaxis to Present at the BIO International Convention
The Aristocrat Group Corp. (ASCC)
The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $0.50, up 0.40%, on 19,621 volume with 15 trades. The stock’s average daily volume over the past 60 days is 57,537, and its 52-week low/high is $0.25/$1.25.
The Aristocrat Group Corp. announced a tour of duty by management today to someplace the people really know how to appreciate and celebrate fine spirits, Las Vegas, where extensive scouting for launch opportunities will be done in advance of the company's debut of their new premium vodka line by brand management division, Luxuria Brands. CEO of ASCC, Robert Federowicz, said the team will be laser-focused on connecting with grass roots market vectors like club owners and beverage directors, as well as other influential personages within the massive restaurant and bar scene, who can really drive the launch of their American-made ultra-premium vodka.
The Aristocrat Group Corp. (ASCC) is a brand management company focused on providing premiere luxury goods through continual innovation. Luxuria Brands, a subsidiary of The Aristocrat Group, has been established to identify and promote unique brands that have mass market appeal across a diverse demographic.
Luxuria Brands is primarily concentrated on distilled spirits industries, with an initial focus on Vodka branding and marketing. The worldwide distilled spirits market is currently worth about $263 billion. In the U.S. alone, Vodka sales between 2004 and 2009 grew 25% from 13.9 million cases to 58.4 million cases. The clear liquor now accounts for almost a third of all distilled spirits consumed and continues to rise in popularity.
The Aristocrat Group is also pursuing opportunities in the women’s lifestyle industry. The World Bank recently estimated that the earning power of women will reach $18 trillion by 2014, which is twice the estimated 2014 GDP of China and India combined. The Aristocrat Group is working to bring fresh, innovative prenatal and postpartum solutions to women who are looking for a more comprehensive approach to wellness.
The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. The company aims to take a leadership position in multiple growing markets that offer opportunities for partnership, sponsorship, and brand awareness activities. The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. Disclaimer
The Aristocrat Group Corp. Company Blog
The Aristocrat Group Corp. News:
ASCC Leadership Travels to Las Vegas to Discuss Launch Opportunities for New Vodka
ASCC Looks to Apple, Social Media to Promote New Brands
ASCC Seeks to Add New Brands Through Mergers & Acquisitions
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.0269, up 27.49%, on 180,800 volume with 6 trades. The stock’s average daily volume over the past 60 days is 274,146, and its 52-week low/high is $0.001/$0.12.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Enters Partnership Agreement With KO Entertainment, Inc.
Consorteum Holdings Reaches Strategic Partnership Agreement With Knockout Gaming
Consorteum Holdings Inc. Reaches Funding Agreement With Private Equity Group
The Guitammer Company Inc. (GTMM)
The QualityStocks Daily Newsletter would like to spotlight The Guitammer Company Inc. (GTMM). Today, The Guitammer Company Inc. closed trading at $0.18, up 12.50%, on 2,300 volume with 2 trades. The stock’s average daily volume over the past 60 days is 18,936, and its 52-week low/high is $0.082/$0.35.
The Guitammer Company Inc. (GTMM) is a leader in low frequency sound products and technology. Its innovative and award winning line of patented ButtKicker-brand low frequency audio transducers let users feel low-frequency sound (bass). ButtKicker brand products are used around the world by leading entertainment and theater companies such as AMC, IMAX and Disney in movie theaters and attractions; by world-famous musicians; in home theaters, simulators and for car audio.
ButtKicker brand products are distributed by Pearl Drums for musicians under the trade name, "Pearl's Throne Thumper by ButtKicker", and factory installed in home theater seating by Palliser Furniture. ButtKicker brand products' patented design makes them musically accurate, powerful and virtually indestructible. The Company is headquartered in Westerville, OH.
The Guitammer Company's newly patented broadcast technology, ButtKicker LIVE! enables the excitement, impact and feeling of sporting events to be broadcast along with the sound and video. ButtKicker LIVE! puts you into the action, whether you're at home or at the event.
ButtKicker Live! technology is available for cable, satellite, fiber optic, IPTV and over-the-air broadcast and has been successfully tested with several major content (sports) providers. ButtKicker(r) and ButtKicker Live!(r) are registered trademarks of The Guitammer Company. Disclaimer
The Guitammer Company Inc. Company Blog
The Guitammer Company Inc. News:
The Guitammer Company Joins D-Tools Manufacturer Vantage Point (MVP) Program
Lumiere Pavilions Jump Starts Chinese New Year With Eighth Theater Installation of Guitammer's Patented "4D" Technology
The Guitammer Company Announces Strong 2012 Financial Results
Advaxis, a clinical-stage biotech company developing immunotherapies for cancer and infectious diseases, has entered into a Memorandum of Understanding (MoU) with Taiwan-based FusionVax under which Advaxis, upon signing a definitive agreement, will exclusively license its lead clinical stage product candidate, ADXS-HPV, to FusionVax for distribution in Asia.
FusionVax develops immunotherapies for the treatment of HPV-associated cancers such as cervical cancer, which is the leading cause of death in Chinese women, says company CEO Dr. HunChi Lin. FusionVax develops its licensed technologies through collaborations with reputable medical centers in Asia including: National Taiwan University, Taipei Medical University, and Mackay Memorial Hospital Medical Center.
“FusionVax is well-positioned to further develop ADXS-HPV clinically and to realize its commercial value in Asia across multiple HPV-associated cancers,” Daniel J. O’Connor, senior vice president, chief legal and business development officer of Advaxis stated in the press release.
Per the MoU, FusionVax will hold the exclusive licensing for the Asia territory, exclusive of India, for all indications, in exchange for an up-front payment to Advaxis, certain event-based financial milestones, an annual exclusive licensing fee, and an annual net sales royalty in countries with issued patents. In exchange for the up-front payment, Advaxis will provide FusionVax an equal amount of Advaxis common stock.
FusionVax will be responsible for conducting clinical trials and pursuing commercialization of ADXS-HPV in Asia, for which Advaxis will pay FusionVax net sales annual royalty on ADXS-HPV in the U.S. of less than 1 percent.
“With five studies currently in the field in four indications, we continue to broaden our data. This MoU is the first milestone on Advaxis’ path to future licensing opportunities,” commented Thomas A. Moore, chairman and CEO of Advaxis.
The companies will share all data generated from their respective clinical trials.
Also reported by Advaxis, Inc. (ADXS) today: First Patient Dosed in Anal Cancer Study
Advaxis, a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases, announced that the first patient has been dosed in a Phase 1/2 study of ADXS-HPV in 25 patients with HPV-associated anal cancer.
Coordinated by the Brown University Oncology Research Group (BrUOG), this study will expand the clinical investigation of ADXS-HPV to now a third tumor type, following cervical cancer and head and neck cancer. ADXS-HPV has been safely administered to more than 190 patients with HPV-associated diseases, and has demonstrated clinical benefit as a single agent or in combination with chemotherapy.
This non-randomized, open-label, multi-center study was designed to assess the safety and effectiveness of ADXS-HPV when combined with standard chemotherapy and radiation treatment for anal cancer. The primary objectives of the trial include the evaluation of adverse events and the evaluation of 6-month clinical response.
“This milestone marks the beginning of the development of ADXS-HPV in diseases beyond cervical cancer. It also will provide valuable insight into the combination of ADXS-HPV with concurrent radiation and chemotherapy,” commented Dr. Robert Petit, VP of Clinical Operations and Medical Affairs at Advaxis.
For more information, visit www.Advaxis.com
Today before the opening bell, The Aristocrat Group announced its executive leadership will be in Sin City this week to scout unique launch opportunities for vodka line set to be released by its brand management division, Luxuria Brands. Known for its attachment to fine spirits, Las Vegas is the perfect city for the ultra-premium spirit’s debut.
“We’ll be speaking to club owners, beverage directors and other influential people in the Las Vegas restaurant and bar scene,” stated ASCC CEO Robert Federowicz. “We’re aiming to make as big a splash as possible with the release of our first distilled spirit, and nobody throws a party like Vegas.”
ASCC believes the successful debut of its American-made vodka will serve an important role in its growing brand management business. Vodka is America’s most popular spirit, accounting for nearly a third of the market by volume and half of its growth. U.S. sales of super-premium vodkas, which typically retail around $30 a bottle, have risen 32 percent in the last two years to $1.2 billion, according to industry trade group the Distilled Spirits Council (DISCUS).
“We’re very proud of the vodka we’ve created, and we can’t wait to give beverage industry professionals a sneak peek in Las Vegas,” Federowicz said.
For more information, visit www.LuxuriaBrands.com/investors.html
Companies that are pioneers, breaking new ground, perhaps even defining new industries, are almost always based less on a desire for money than a passion for a particular field. The Guitammer Company is an example. The company was founded by Ken McCaw, an accomplished bass player, composer, and producer, now on the Board of Directors. His personal passion for making music led him to tackle a common frustration experienced by bass players and drummers. He wanted to actually feel the low end frequencies without having to increase stage monitor volume so loud that it disturbed the rest of the band.
He turned to sound and equipment expert Marvin Clamme, a former sound engineer for Tom Jones, Merle Haggard, the Beach Boys, and others. Together they were able to develop magnetically suspended audio transducers, now marketed under the ButtKicker® brand, that were able to successfully transform low-frequency sounds into physical vibrations, essentially sounds that could be felt rather than heard. They eventually obtained a patent for the technology and began introducing the world to this new perceptual dimension.
It wasn’t long before the technology began to catch on, and today it is used for tactile chair vibrations by some of the biggest entertainment companies in the world to enhance the consumer experience at movies, live performances, and other entertainment settings, including Disney, IMAX, and AMC. With over 10,000 seats and 86 different locations in 11 countries now enabled, it appears to be an idea whose time has come.
One of the markets where Guitammer is growing most rapidly is China, a nation where cinema sales are growing at 6% per year, and where approximately 10 new screens go up every day. China now exceeds Japan in cinema sales. It’s also where Guitammer recently announced that it has landed its eighth theater installation, with Sichuan Lumière Cinema Co. Ltd. (Lumière Pavilions) of Beijing. Lumiere Pavilions is known for developing high-end cinemas in China.
For more information, visit www.Guitammer.com
Immunotherapy and stem cell technology represent two of the hottest fields in medical science today. Although there is still much research to be done, immunotherapy is seen as the ultimate weapon against some of the most intractable diseases, essentially having the best potential to hunt out and destroy bad cells. And stem cell technology is seen as the best hope for regenerating the body, essentially building more good cells.
But there’s a third less known but no less important component to the future of modern medicine. It’s called pharmacogenomics, a field of study derived from the Human Genome Project. The goal of pharmacogenomics is to provide doctors and researchers the tools necessary to accurately assess genetic variations in patients, and eventually provide drug treatment options that are finely tuned to each patient’s needs, avoiding the trial-and-error approach that doctors are so often forced to rely on. It’s a critical science that could greatly leverage other medical technologies.
Differences in how drugs are metabolized, and their ultimate effects, frequently have a genetic base, and knowing a patient’s genetic makeup could mean the difference between a treatment’s success and failure. When Rainbow Coral Corp. recently announced its plan to partner with a genome-mapping facility in Houston, they were targeting one of the fastest growing segments in biotech, the genetic testing sector, expected to reach $2.2 billion by 2017.
It’s just one of the company’s moves to implement its strategy of developing the best research and drug therapy products. Rainbow also recently acquired a new equity interest in Nano3D Biosciences, an emerging biotech game-changer, whose Bio-Assembler technology may soon allow researchers to dramatically shorten the development timeline for new drugs and treatments, an area that has the potential for explosive growth.
For additional information, visit www.RainbowbioSciences.com
Today's Top 3
The QualityStocks Public Company Sponsor News